Edward E. Penhoet Ph.D.

Edward E. Penhoet Ph.D.

Director at Alta Partners

Are you Edward E. Penhoet Ph.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Edward E. Penhoet Ph.D.'s network.
  • FOLLOW changes in Edward E. Penhoet Ph.D.'s employment.
  • CONNECT with Edward E. Penhoet Ph.D. through your network of contacts.

Edward E. Penhoet Ph.D.'s Executive Work History


Current
Director,
Director
Equilar on 02/13/2018
Alta Partners
Board Member,
Board Member
Equilar on 03/01/2022
UCSF Benioff Children's Hospital Oakland
Past
To view Edward E. Penhoet Ph.D.'s complete executive work history,
Education
Ph.D., University of Washington
Age
81
 

Edward E. Penhoet Ph.D.'s Biography


Edward Penhoet is associate dean of biology at the University of California, Berkeley and professor emeritus of biochemistry and of health policy and management. He was a founder of Chiron Corporation, a pioneer in the business of biotechnology, and served as CEO from 1981 to 1998. He was president of the Gordon and Betty Moore Foundation from 2004 to 2008. He earned his bachelor’s degree in biology from Stanford University and his doctorate in biochemistry from the University of Washington. He completed a postdoctoral fellowship at the University of California, San Diego.

Source: UCSF Benioff Children's Hospital Oakland on 03/01/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Edward E. Penhoet Ph.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Edward E. Penhoet Ph.D.'s network.
  • FOLLOW changes in Edward E. Penhoet Ph.D.'s employment.
  • CONNECT with Edward E. Penhoet Ph.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Edward E. Penhoet Ph.D.

Edward E. Penhoet Ph.D.'s Connections (191)


Yves Joseph Ribeill Ph.D.
Chairman, Calyxt, Inc.
Christopher Whitmore
Chief Financial Officer, Immune-Onc Therapeutics
Peder K. Jensen M.D.
Board Member, Acorda Therapeutics, Inc.
Donald L. Drakeman Ph.D.
Advisor, Capella BioScience
Juan Carlos Jaen Ph.D.
President and Director, Arcus Biosciences, Inc.
James N. Wilson
Chairman, Corcept Therapeutics Incorporated
Anthony P. Adamis M.D.
Board Member, EyePoint Pharmaceuticals, Inc.
George Leonard Baker Jr.
Board Member, Corcept Therapeutics Incorporated
Harold E. Van Wart Ph.D.
Former President and Chief Executive Officer, CymaBay Therapeutics, Inc.
Timothy P. Walbert
Chairman, President and Chief Executive Officer, Horizon Therapeutics Public Limited Company